Streetbeat News

TCBP

TC Biopharm (Holdings) Plc

https://www.tcbiopharm.com

Industry

Biotechnology

TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat COVID-19. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.

Open

0.78

Mkt cap

188K

Volume

27M

High

0.96

P/E Ratio

N/A

52-wk high

138.00

Low

0.56

Div yield

N/A

52-wk low

0.56

In Wednesday's intraday session, several healthcare stocks experienced significant movements. NexImmune (NEXI) saw a substantial increase of 230.5%, while ABVC BioPharma (ABVC) and First Wave BioPharma (FWBI) also posted notable gains. Conversely, Nemaura Medical (NMRD), TC BioPharm (TCBP), and Esperion Therapeutics (ESPR) were among the stocks that declined. These movements reflect the volatility and rapid changes in the healthcare sector, impacting the market value of these companies.

Portfolio Pulse from Benzinga Insights

January 03, 2024 | 5:31 pm

In Friday's pre-market session, several healthcare stocks experienced significant movements. Karuna Therapeutics (KRTX) saw a substantial increase of 47.9%, while AlloVir (ALVR) faced a sharp decline of 57.5%. Other notable gainers include Senti Biosciences (SNTI), SenesTech (SNES), Galecto (GLTO), TC BioPharm (TCBP), and Reviva Pharmaceuticals (RVPH). Conversely, 60 Degrees (SXTP), Nanobiotix (NBTX), DMK Pharmaceuticals (DMK), Oncternal Therapeutics (ONCT), and ThermoGenesis Holdings (THMO) were among the losers.

Portfolio Pulse from Benzinga Insights

December 22, 2023 | 1:07 pm

In Wednesday's after-market session, several healthcare stocks experienced significant movements. Atara Biotherapeutics (ATRA) saw a 24.3% increase, while MoonLake (MLTX) rose by 12.98%. TC BioPharm (TCBP), Perspective Therapeutics (CATX), Lucy Scientific Discovery (LSDI), and Calliditas Therapeutics (CALT) also posted gains. Conversely, Jin Medical International (ZJYL) led the losers with a 10.7% decline, followed by Avalo Therapeutics (AVTX), Eiger BioPharmaceuticals (EIGR), Monogram Orthopaedics (MGRM), LogicMark (LGMK), and Aclarion (ACON) with notable decreases.

Portfolio Pulse from Benzinga Insights

December 20, 2023 | 9:31 pm

TC BioPharm (TCBP) has announced the pricing of its public offering at $2 per ADS, aiming to raise $3.5 million through the sale of 1,750,000 ADS.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 1:15 pm

Despegar.com, Corp. (DESP) shares rose by 16.4% after raising its FY23 revenue guidance. Other stocks moved in Wednesday's mid-day session with significant gainers including Shattuck Labs (STTK), ReShape Lifesciences (RSLS), and C4 Therapeutics (CCCC), among others. Losers included Hywin Holdings (HYW), Boqii Holding (BQ), and Processa Pharmaceuticals (PCSA). Notable mentions include ABM Industries (ABM) with positive results and guidance, and Take-Two Interactive Software (TTWO) being added to the Nasdaq-100 Index.

Portfolio Pulse from Avi Kapoor

December 13, 2023 | 6:40 pm

TC BioPharm announced a change in the ratio of its ADSs to ordinary shares. Effective December 15, 2023, each ADS will represent 20 ordinary shares, a change from the current 1:1 ratio.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 11:34 am

In Monday's pre-market session, several healthcare stocks experienced significant movements. Pasithea Therapeutics (KTTA) saw a sharp rise of 86.6%, while Assure Holdings (IONM) and Poseida Therapeutics (PSTX) also saw substantial gains. On the downside, Cogent Biosciences (COGT) and X4 Pharmaceuticals (XFOR) faced notable declines. These movements reflect changes in investor sentiment and could be driven by recent company news, market trends, or broader sector shifts.

Portfolio Pulse from Benzinga Insights

December 11, 2023 | 1:06 pm

Cerevel Therapeutics Holdings, Inc. (CERE) shares surged approximately 15% in pre-market trading after AbbVie Inc. (ABBV) announced plans to acquire Cerevel for $8.7 billion, or $45 per share in cash. The acquisition is expected to close in mid-2024. Other stocks experienced pre-market movements, with notable gainers including Hempacco Co., Inc. (HPCO), MicroAlgo Inc. (MLGO), and AerSale Corporation (ASLE), and significant losers such as ZyVersa Therapeutics, Inc. (ZVSA), Red Cat Holdings, Inc. (RCAT), and Chewy, Inc. (CHWY).

Portfolio Pulse from Avi Kapoor

December 07, 2023 | 12:59 pm

In Monday's after-market session, several healthcare stocks experienced significant movements. SenesTech (SNES) saw a 42.0% increase, while Centessa Pharmaceuticals (CNTA) dropped by 10.6%. Other notable gainers include TC BioPharm (TCBP), Heart Test Laboratories (HSCS), UpHealth (UPH), AcelRx Pharmaceuticals (ACRX), and Sientra (SIEN). On the losing side, Redhill Biopharma (RDHL), OneMedNet (ONMD), Tharimmune (THAR), Envoy Medical (COCH), and Leap Therapeutics (LPTX) saw declines in their stock prices.

Portfolio Pulse from Benzinga Insights

November 27, 2023 | 9:31 pm

Anavex Life Sciences Corp. (AVXL) shares dropped by 10% after reporting a Q4 net loss of $10.1 million, or 12 cents per share, compared to a net loss of $14.3 million, or 18 cents per share, in the same period last year. Other stocks experienced significant movements in Monday's mid-day session, with notable gainers including RedHill Biopharma Ltd. (RDHL), Biodexa Pharmaceuticals Plc (BDRX), and Tharimmune, Inc. (THAR), among others. Losers included 10X Capital Venture Acquisition Corp. II (VCXA), BioNexus Gene Lab Corp. (BGLC), and HCW Biologics Inc. (HCWB). Affirm Holdings, Inc. (AFRM) saw a jump of 13.7% following positive 'buy now, pay later' predictions for Cyber Monday.

Portfolio Pulse from Lisa Levin

November 27, 2023 | 6:41 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.